Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$866,475
+$331,241 QoQ
Shares Held
288,825
+228.1% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $503,697,022 across 26 Diagnostics & Research names. XGN ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
610,530 | $115,756,488 | |
| 2 | A |
Agilent Technologies, Inc.
|
926,259 | $105,575,000 | |
| 3 | DGX |
Quest Diagnostics Inc
|
345,788 | $67,767,532 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
100,309 | $56,362,624 | |
| 5 | LH |
Labcorp Holdings Inc.
|
140,165 | $37,397,423 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
69,837 | $34,326,980 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
58,875 | $28,271,186 | |
| 8 | GH |
Guardant Health, Inc.
|
191,740 | $17,711,023 |
All Filings in XGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $866,475 | 288,825 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $535,234 | 88,032 | Shares | Defined | 2026-02-13 | |
| 2020-12-31 | $133,029 | 10,078 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $193,515 | 17,852 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $171,940 | 13,855 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $257,797 | 16,173 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||